Gonzalez-Montes, Y, Osca-Gelis, G, Rodriguez-Romanos, R, Villavicencio, A, González-Bártulos, M, Llopis, F, Clapes, V, Oriol, A, Sureda, A, Escoda, L, Sarrà, J, Garzó, A, Lloveras, N, Gómez, B, Granada, I, Gallardo, D
CD200 genotype is associated with clinical outcome of patients with multiple myeloma
Huguet, M, Casabella, L, Suero, M, Blanco, N, Ros, T, Mart n, JA, Vigo, A, Carrascosa, T, Jim nez, C, Kara, M, Ferreiro, JJ, L pez, J, de Heredia, CD, L pez, C, Gil, E, Albo, C, Arcarons, J, Perla, A, Salcedo, I, Escoda, L, Blanquer, M, Hernani, R, Espana, L, Gonz lez, S, Navarro, J, Mu oz, C, Alacid, M, Chamorro, C, G mez, C, Mart n, MP, Rodr guez, AM, S nchez, P, Callejas, M, Monta o, JM, Osca, G, Arzuaga, J, Gonz lez, MS, Morgades, M, Torrent, A, Jim nez, MJ
EBMT REGISTRY: HOW IS IT CARRIED OUT IN THE SPANISH TRANSPLANT CENTRES? A STUDY ON BEHALF OF SPANISH HEMATOPOIETIC STEM CELL TRANSPLANTATION GROUP (GETH-TC)
Gonzalez-Montes Y, Rodriguez-Romanos R, Villavicencio A, Osca-Gelis G, González-Bártulos M, Llopis F, Clapes V, Oriol A, Sureda A, Escoda L, Sarrà J, Garzó A, Lloveras N, Díez I, Granada I, Gallardo D
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma
Bosch-Barrera, J, Teixidor, E, Sanvisens, A, Puigdemont, M, Trallero, J, Vila, AV, Osca, G, Roberte, MV, Priego, N, Sais, E, Martínez, AH, Ortega, JS, Cuyàs, E, Verdura, S, Puig, J, Pineda, V, Martí-Navas, M, Calvo, A, Menendez, JA, Marcos-Gragera, R, Valiente, M
Using Silibinin to Target STAT3-Positive Reactive Astrocytes for the Treatment of NSCLC Brain Metastases
Díaz-Santa J, Rodríguez-Romanos R, Coll R, Osca G, Pratcorona M, González-Bártulos M, Garrido A, Angona A, Talarn C, Tormo M, Arnan M, Vives S, Salamero O, Tuset E, Lloveras N, Díez I, Zamora L, Bargay J, Sampol A, Cruz D, Vila J, Sitges M, Garcia A, Vall-Llovera F, Esteve J, Sierra J, Gallardo D
5 '-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics
Rubió-Casadevall J, Carbó-Bagué A, Puigdemont M, Osca-Gelis G, Oliveras G, Vilar-Coromina N, Ferrer-Fabrega B, Urban A, Llobet-Roma M, Martín-Romero F, Perez-Bueno F, Marcos-Gragera R
Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor
Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy
Fort Culillas, R., Carmona Garcia, C., Osca Geli, G., Marcos-Gragera, R., Puigdemont Guinart, M., Biarnes Costa, J., Lopez-Ben, S., Garcia Velasco, A., Guardeno Sanchez, R.
Incidence and survival of pancreatic neuroendocrine tumours in Girona, Spain
